Restoring synaptic function in Down Syndrome mice
恢复唐氏综合症小鼠的突触功能
基本信息
- 批准号:9340289
- 负责人:
- 金额:$ 23.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAngelman SyndromeBehaviorBehavioralBiological MarkersBrainBreedingChronicCognitiveCognitive deficitsCommunicationComplexCrossbreedingDown SyndromeFunctional disorderFutureGeneticGlutamatesGoalsHereditary DiseaseImpaired cognitionImpairmentInterventionKnock-in MouseLeadLearningLong-Term DepressionLong-Term PotentiationMemoryMental DepressionModelingMolecularMusMutant Strains MiceMutationNeurotransmittersNitric OxidePatientsPharmacological TreatmentPharmacologyPhosphorylationPublishingReactive Oxygen SpeciesRegimenSynapsesSynaptic plasticitySyndromeSystemTestingTherapeuticTreatment ProtocolsWorkantioxidant therapybrain cellcalmodulin-dependent protein kinase IIcognitive functionfear memorygenetic approachimprovedinsightmouse modelnovelnovel therapeutic interventionnovel therapeuticsoxidationrestorationscreeningsuccesssynaptic functiontooltransmission processunpublished works
项目摘要
Project Summary
Down Syndrome (DS) model mice have three abnormalities in synaptic functions that can
explain the cognitive deficits in DS: Decreased long-term potentiation (LTP) and enhanced long-
term depression (LTD) of glutamatergic synapses, as well as enhanced inhibitory transmission
at GABAergic synapses. Our recent published work indicates that all three observed synaptic
dysfunction should be caused by the hyper-phosphorylation of the Ca2+/calmodulin-dependent
protein kinase II (CaMKII) seen in DS mice. Our recent unpublished work indicates an
intriguing possible mechanism for the cause of CaMKII hyper-phosphorylation in the DS mice.
Importantly, this mechanism could also be targeted by pharmacological intervention.
As a proof of principle, this project will focus on two aspects of the overall question:
(Aim 1) Testing the underlying cause for CaMKII hyper-phosphorylation in DS mice (using a
new mutant mouse line that has been generated in the lab and that is incompetent for the
proposed underlying mechanism);
(Aim 2) Restoration of normal LTP by genetic reversal of T305/306 hyper-phosphorylation in
DS mice (using a CaMKII T305/306AV mutant mouse line currently available to the lab).
Future studies will test restoration of the other synaptic dysfunctions in DS, restoration of
cognitive behavioral tasks, and restoration also by pharmacological means.
Notably, while it may seem preposterous to propose a reversal of cognitive impairments in a
very complex syndrome by a rather simple intervention, there is actually prior precedent for
success: In a model of a different genetic condition that causes cognitive impairments,
Angelman Syndrome (AS), CaMKII is also hyper-phosphorylated, and even heterozygous
T305/306AV mutation was sufficient to restore both normal LTP and spatial learning. In
contrast to AS, the hyper-phosphorylation of CaMKII in DS could be targeted also
pharmacologically (if our hypothesized underlying mechanism is correct). Thus, this project will
not only provide significant further insight into the mechanism underlying normal synaptic
functions and their impairments in DS, but also has tremendous potential for directly opening a
new therapeutic avenue for restoring cognitive functions in patients with DS.
项目摘要
唐氏综合症(DS)模型小鼠在突触功能中具有三种异常
解释DS中的认知缺陷:长期增强(LTP)的降低并增强了长期
谷氨酸能突触的术语抑郁(LTD),并增强了抑制性传播
在GABA能突触。我们最近发表的工作表明,这三个观察到了突触
功能障碍应由Ca2+/钙调蛋白依赖性的高磷酸化引起
蛋白激酶II(CAMKII)在DS小鼠中看到。我们最近未发表的工作表明
DS小鼠中CAMKII高磷酸化原因的可能机制。
重要的是,该机制也可以通过药理学干预来针对。
作为原则的证明,该项目将重点介绍总体问题的两个方面:
(AIM 1)测试DS小鼠中CaMKII高磷酸化的根本原因(使用A
在实验室中生成的新型突变鼠系,对于
提出的潜在机制);
(AIM 2)通过T305/306在遗传逆转中恢复正常LTP。
DS小鼠(使用当前可用于实验室可用的CAMKII T305/306AV突变鼠标线)。
未来的研究将测试DS中其他突触功能障碍的恢复,恢复
认知行为任务和药理手段的恢复。
值得注意的是,虽然提出对认知障碍的逆转似乎是荒谬的
非常简单的干预措施非常复杂的综合征,实际上有先前的先例
成功:在导致认知障碍的不同遗传条件的模型中,
Angelman综合征(AS),Camkii也被过度磷酸化,甚至是杂合子
T305/306AV突变足以恢复正常的LTP和空间学习。在
与AS形成鲜明对比的是,CaMKII在DS中的高磷酸化也可以针对
在药理学上(如果我们假设的潜在机制是正确的)。因此,这个项目将
不仅可以进一步了解正常突触的基础机制
功能及其在DS中的损害,但也具有直接打开的巨大潜力
用于恢复DS患者认知功能的新治疗途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
K. Ulrich Bayer其他文献
K. Ulrich Bayer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('K. Ulrich Bayer', 18)}}的其他基金
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention
CaMKII 在全脑缺血中的作用:机制和治疗干预
- 批准号:
10531925 - 财政年份:2021
- 资助金额:
$ 23.33万 - 项目类别:
CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention
CaMKII 在全脑缺血中的作用:机制和治疗干预
- 批准号:
10328983 - 财政年份:2021
- 资助金额:
$ 23.33万 - 项目类别:
CaMKII nitrosylation in the age-related decline of synaptic plasticity
CaMKII 亚硝基化在与年龄相关的突触可塑性下降中的作用
- 批准号:
10222559 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
CaMKII nitrosylation in the age-related decline of synaptic plasticity
CaMKII 亚硝基化在与年龄相关的突触可塑性下降中的作用
- 批准号:
10454912 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
CaMKII nitrosylation in the age-related decline of synaptic plasticity
CaMKII 亚硝基化在与年龄相关的突触可塑性下降中的作用
- 批准号:
10671685 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
CaMKII nitrosylation in the age-related decline of synaptic plasticity
CaMKII 亚硝基化在与年龄相关的突触可塑性下降中的作用
- 批准号:
10444721 - 财政年份:2020
- 资助金额:
$ 23.33万 - 项目类别:
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction
β淀粉样蛋白诱导的突触功能障碍中的突触后激酶/磷酸酶网络
- 批准号:
10450777 - 财政年份:2018
- 资助金额:
$ 23.33万 - 项目类别:
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction
β淀粉样蛋白诱导的突触功能障碍中的突触后激酶/磷酸酶网络
- 批准号:
10207804 - 财政年份:2018
- 资助金额:
$ 23.33万 - 项目类别:
Postsynaptic kinase/phosphatase networks in amyloid beta-induced synaptic dysfunction
β淀粉样蛋白诱导的突触功能障碍中的突触后激酶/磷酸酶网络
- 批准号:
9791023 - 财政年份:2018
- 资助金额:
$ 23.33万 - 项目类别:
Restoring synaptic function in Down Syndrome mice
恢复唐氏综合症小鼠的突触功能
- 批准号:
9243583 - 财政年份:2016
- 资助金额:
$ 23.33万 - 项目类别:
相似国自然基金
天使症候群(Angelman Syndrome,AS)TrkB信号损伤的机制研究及靶向干预
- 批准号:31371139
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on GABRB3-deficient neocortical progenitors
母体免疫激活对 GABRB3 缺陷的新皮质祖细胞的影响
- 批准号:
9275259 - 财政年份:2016
- 资助金额:
$ 23.33万 - 项目类别:
Restoring synaptic function in Down Syndrome mice
恢复唐氏综合症小鼠的突触功能
- 批准号:
9243583 - 财政年份:2016
- 资助金额:
$ 23.33万 - 项目类别:
Effects of maternal immune activation on GABRB3-deficient neocortical progenitors
母体免疫激活对 GABRB3 缺陷的新皮质祖细胞的影响
- 批准号:
9123298 - 财政年份:2016
- 资助金额:
$ 23.33万 - 项目类别: